# Career Enhancement Program

> **NIH NIH P50** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2022 · $78,814

## Abstract

PROJECT SUMMARY
The NYU Melanoma SPORE Career Enhancement Program (CEP) will prepare investigators for independent 
translational research careers to study melanoma. To accomplish this goal, the CEP will select, support, and 
guide individuals focused on becoming leading translational researchers in melanoma. The Director of the 
CEP, Dr. Seth Orlow, Chairman of the Department of Dermatology at NYU Langone Health (NYULH), has an 
established track record of success in training translational scientists. The NYU Melanoma SPORE CEP will 
support outstanding candidates for up to 2 full years by providing both financial assistance and academic 
guidance. This will enable awardees to establish successful investigations related to melanoma, and 
simultaneously provide a solid foundation to further develop full research projects within the SPORE. The CEP 
will nurture and grow the pipeline of talent in melanoma translational research by recruiting and supporting 
promising junior or rising faculty in addition to more established investigators with the potential to become 
accomplished independent investigators focused on melanoma translational research. The CEP will monitor, 
oversee, and mentor each individual chosen for the CEP to ensure the investigator’s progress towards a 
successful independent career in melanoma translational research, in addition to availing awardees to 
programs and collaborations to build the skills necessary to achieve this end. The CEP is strongly committed to 
training women and underrepresented minority candidates at all levels for careers as independent 
investigators. Unique strengths that will be beneficial to CEP awardees include existing formal coursework 
offered by NYU that leads to a Master of Science degree in translational research and a large pool of 
accomplished mentors across multiple specialties. The CEP is thematically aligned to the NYU Melanoma 
SPORE’s overarching mission to use personalized biomarkers to optimize clinical management of melanoma 
patients, and is highly integrated with the programs and projects of the SPORE. This thematic integration will 
enable the CEP to maximize the progress of the awardees careers.

## Key facts

- **NIH application ID:** 10434094
- **Project number:** 5P50CA225450-04
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** SETH J. ORLOW
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $78,814
- **Award type:** 5
- **Project period:** 2019-07-19 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10434094

## Citation

> US National Institutes of Health, RePORTER application 10434094, Career Enhancement Program (5P50CA225450-04). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10434094. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*